Biotech backer Atlas Venture keeps up blistering fundraising pace with $450m Fund XIII close

• Mike Didymus
• March 7, 2022

Biotech-focused investment firm Atlas Venture has hit $450m for the final close of its oversubscribed thirteenth fund. The post Biotech backer Atlas Venture keeps up blistering fundraising pace with $450m Fund XIII close first appeared